CI

At a glance

ClinicalIndex Comparison Record
N/ACompleted· 2,320 enrolled
Drug / intervention
Iodinated contrast agentsdrug
Likely dose
Not stated in record
Structured eligibility isn't available for this trial yet — see the full criteria in the Eligibility tab below.

Standardized by ClinicalIndex from the ClinicalTrials.gov record · verify against the source.

Search/NCT02959827
NCT02959827N/ACompleted

Iodinated Contrast Agents and Risk of Hypothyroidism in Young Children in the United States

Bayer·observational·Posted Nov 9, 2016·Updated Jan 30, 2019

In Brief

An observational study evaluating Iodinated contrast agents for Hypothyroidism. Completed, enrolled 2,320 participants across 1 site.

Detailed Summary

This study will estimate the incidence of hypothyroidism in a pediatric population of children under age 4, based on data from the US-based Kaiser Permanente Northern California database, which were exposed to iodinated contrast agent through having a diagnostic procedure.

Study Details

Study Typeobservational
Allocation--
Masking--
Primary Purpose--
ConditionsHypothyroidism
CountriesUnited States
Collaborators--

Timeline

N/ACompletedFinished
2017201820192020202120222023202420252026
First PostedNov 9, 2016
Enrollment StartOct 15, 2016
Primary CompletionJun 15, 2017
TodayJul 2, 2026
Enrollment to primary: 8 monthsPosted 9.6 years ago

Interventions

Iodinated contrast agentsdrug

Use of iodine contrast agents and doses following the decision of the treating physician.